Navigation Links
Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
Date:9/27/2011

SAN DIEGO, Sept. 27, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that an elagolix podium presentation has been accepted for the scientific program at the 2011 Annual Meeting of the American Society for Reproductive Medicine, to be held October 15-19, 2011 in Orlando, Florida. This annual meeting draws over 4,000 experts from around the world to address current topics related to human reproduction.  

"We are very pleased to participate in the annual meeting of the American Society for Reproductive Medicine," said Chris O'Brien, M.D., Chief Medical Officer at Neurocrine. "Endometriosis is a leading cause of infertility in women and this scientific meeting brings together the world's thought leaders in obstetrics, gynecology, and endocrinology to discuss the latest advances in the field. We look forward to sharing our elagolix clinical data at this meeting."

An abstract from the Daisy Petal clinical study of elagolix for the treatment of endometriosis-associated pain will be presented at the 67th Annual Meeting of the American Society for Reproductive Medicine on Tuesday, October 18, 2011 at 4:15 pm during the abstract sessions. Bruce Carr, M.D. the Paul C. MacDonald Distinguished Chair in Obstetrics and Gynecology at University of Texas Southwestern Medical School will present "A Novel Oral GnRH Antagonist, Elagolix, is Effective For Reducing Endometriosis-Associated Pelvic Pain: Results of a 24-Week Randomized Study."

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-rela
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
2. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
3. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
5. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
6. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
7. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
8. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
9. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
10. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014 ... they have added 14 new vendors so far ... Creekridge,s newest vendors are from both ... mid-size domestic organizations to large, well-known multi-national companies. ... Creekridge,s diversified suite of financing products including: standard ...
(Date:7/23/2014)... July 23, 2014 PositiveID Corp. (OTCQB: PSID), ... , is an emerging player in the bio-threat ... bio-threat detection and rapid medical testing. The Company,s ... Bio-agent Autonomous Networked Detector), was developed under contract ... Science & Technology directorate, and $30 million of ...
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... MISSISSAUGA, Ontario, April 18, 2011 Valeant Pharmaceuticals International, ... filed a revised preliminary consent solicitation statement in which ... of proposed directors in connection with its previously announced ... Inc. (NASDAQ: CEPH).  Mr. Friedman will join the seven-member ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 2Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 3Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 4
(Date:7/23/2014)... Bodybuilding.com, the Internet’s most-visited bodybuilding and ... supplements, has officially opened the polls for their tenth ... fastest growing sports nutrition company, is up for eight ... Year, Best Tasting Protein of the Year- Whey-HD™, Most ... year - Whey-HD™, Pre-workout Supplement of the Year - ...
(Date:7/23/2014)... Olympic gold medal-winning speed skater Chad Hedrick visited ... 18. Hedrick visited Roanoke as the special guest of ... event celebrating its 25th Anniversary in 2014. Foot Levelers ... of the Commonwealth Games, which like Foot Levelers promotes ... activity levels. , Hedrick, a native of Houston, earned ...
(Date:7/23/2014)... effort to catalog the molecular causes of stomach ... have identified four subtypes of tumors based on ... the new classification promises to advance clinical research ... killer worldwide. , In a report in ... Research Network said they analyzed 295 samples of ...
(Date:7/23/2014)... the likelihood of forming false memories, according to research ... the Association for Psychological Science. , In a study ... University of California, Irvine and colleagues, sleep-deprived people who ... read false information about the photos were more likely ... than were those who got a full night,s sleep. ...
(Date:7/23/2014)... This report defines and segments the "EHV Transmission ... East & Africa, and Americas) - Global Trends & ... and forecasts of the global revenue. The global EHV ... billion in 2014 to nearly $14 billion by 2019 ... 49 Market Tables and 10 Figures Spread Through 220 ...
Breaking Medicine News(10 mins):Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Sleep deprivation may increase susceptibility to false memories 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4
... N.C. -- Researchers at Wake Forest Baptist Medical Center,s Institute ... that may play a critical role in how the human ... of Pancreas , the research team says the protein ... "This data may change the current thinking about ...
... Journal of Clinical Oncology shows that most patients ... surgery recover an average quality of life. However, quality of ... level that remains much lower than the average population in ... that hospitals must be better at identifying this patient group. ...
... investigates the challenges of disseminating clinical research findings in peer-reviewed ... fewer than half of a sample of trials primarily or ... published within 30 months of completing the clinical trial. ... British Medical Journal , which focuses on the topic ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... loss surgery appear to reduce their risk of heart ... heart-health benefits seem to be connected with metabolic changes that ... than the weight loss, the researchers say. "Bariatric surgery ...
... 3 (HealthDay News) -- Sexual satisfaction increases with age among ... those who don,t have sex are satisfied with their sex ... in a planned community in the San Diego area ... study participants, average age was 67 years and 63 percent ...
... time heals all wounds Wound healing requires complex ... immune cells. As healing progresses, the growth of new blood ... cells (EPCs) are cells that come from the bone marrow ... the signals that direct their emigration from the bone marrow ...
Cached Medicine News:Health News:Researchers discover protein that may represent new target for treating type 1 diabetes 2Health News:Impaired quality of life: A warning signal after oesophageal cancer surgery 2Health News:Many NIH-funded clinical trials go unpublished over 2 years after completion 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 3Health News:Women's Sexual Satisfaction Often Rises With Age: Study 2Health News:Preview of articles to be published Jan. 3, 2012 2Health News:Preview of articles to be published Jan. 3, 2012 3Health News:Preview of articles to be published Jan. 3, 2012 4Health News:Preview of articles to be published Jan. 3, 2012 5Health News:Preview of articles to be published Jan. 3, 2012 6Health News:Preview of articles to be published Jan. 3, 2012 7Health News:Preview of articles to be published Jan. 3, 2012 8
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... SL1 developed by STORZ MEDICAL is the ... in the field of kidney stone lithotripsy ... requirements to be met by orthopaedic apparatus ... been outlined above. The MINILITH SL1 is ...
... transportable, the Dornier Compact Delta lithotripsy system features ... patient. The systems shock source and C-arm are ... avoid the risk of misalignment. The therapy head ... its motorized lateral and horizontal movement and can ...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
Medicine Products: